Skip to main content
Search

Ewen Callaway

1 related articles

Subscribe to updates
  1. Nature

    Drug Firms' Private Data Supercharge AI Protein Models

    An AI Structural Biology (AISB) network of pharmaceutical companies fine-tuned the open-source model OpenFold3 on 20,167 proprietary protein-ligand structures from five companies; on a held-out test set of 1,056 protein-ligand structures, the model achieved high-accuracy predictions for more than half, compared with one-third for the public version of OpenFold3 and around 40% for the competing open-source model Boltz-2, and it also outperformed models trained only on individual companies' siloed data, indicating that pooling private data markedly improves protein-ligand interaction prediction.

You’re all caught up